Brexit and second medical use patent claims were two topics featured in the roundtable discussions at Life Sciences Patent Network (LSPN) Europe, a conference held in London.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
LSPN Europe 2017, Life Sciences Patent Network Europe, in-house counsel, second medical use, round table, European Medicines Agency,